Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer.
A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer. Clin Genitourin Cancer. 2022 Dec; 20(6):575-580.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Angiogenesis Inhibitors
Humans
Male
Middle Aged
Prostate-Specific Antigen
Prostatic Neoplasms, Castration-Resistant
Treatment Outcome
authors with profiles
Walter M. Stadler